Update on the SOUTH study: Following a detailed data cleaning process by our team in Kampala, we were able to perform statistical analyses of the complete dataset from the SOUTH study. With the much appreciated help of Bruno Ledergerber, Christine Sekaggya submitted an abstract which was presented at this year’s HIV meeting in Glasgow. She is now working on the main publication of the study’s promising results on pharmacokinetics in TB/HIV co-infected adults.
Update on the RHINOS study: Global challenges by emerging HIV drug resistance in some parts of the world, as well as first results from the RHINOS study were discussed at this year’s scientific retreat of the Swiss HIV Cohort Study in Berne, Switzerland. Following these lively discussions, we are happy to announce that Nadine Bachmann from the research group around Roger Kouyos joined our group and now leads the statistical analysis of this study’s data. We are working together closely on the main manuscript and benefit from her professional input tremendously. Welcome Nadine!
Introducing the RHINUP study: In parallel, we set up a follow-up study of the RHINOS study (RHINOS follow-up or short RHIN-UP), which will look into the outcome of patients identified by the RHINOS study with virological failure and HIV drug resistance one year ago. Especially patients with virological failure due to drug resistance to two or more drug classes have limited treatment options in a resource-constrained setting. It is our goal to provide accurate numbers, identify risk factors for treatment failure, and ultimately contribute to improved care.
